TrkB expression is similarly affected in the caudate nucleus and motor cortex of post-mortem tissue from HD brains, with some striking reports indicating up to an 80% loss of TrkB immunoreactivity in HD vs. control brains [82]. This evidence concerns the gene NTRK2 and Huntington disease.